Abivax S.A.

ABVX· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$124.78-0.11%

2026-08-03

Valuation Metrics

Abivax S.A.'s Market Cap is $9.94B. At end of 2025 it was $919M. Ranked #951 of 3,112 in US market (top 31%), #305 of 1,445 on NASDAQ (top 21%), #47 of 269 in Pharmaceuticals, Biotechnology & Life Sciences (top 17%) by Market Cap.

Investment Metrics(as of 2026-08-03)

Metric	Value	Rank
Size
Market Cap	$9.94B	US#951/3,112 Sec#47/269
Revenue	$0.00	US#2,974/3,112 Sec#204/269
Net Income	$-381M	US—/3,112 Sec—/269
Total Assets	$686M	US#2,614/3,112 Sec#127/269
Net Assets	$534M	US#2,203/3,112 Sec#105/269
Value
P/B	18.61x	US#2,798/3,112 Sec#231/269
FCF Yield	-1.78%	US—/3,112 Sec—/269
Profitability
ROE	-71.30%	US#2,807/3,112 Sec#202/269
ROA	-55.54%	US#2,986/3,112 Sec#230/269
Financial Health
Debt Ratio	28.37%	US#307/3,112 Sec#102/269
Total Debt	$38M	US#2,598/3,112 Sec#158/269
FCF	$-177M	US#2,713/3,112 Sec#207/269
Cash	$607M	US#952/3,112 Sec#46/269
Current Ratio	8.75x	US#285/3,112 Sec#92/269
Performance
1Y Return	73.45%	US#463/3,112 Sec#99/269
1M Return	-13.74%	US#2,767/3,112 Sec#195/269
From 52W High	-16.16%	US#1,477/3,112 Sec#86/269
1Y MDD	-50.11%	US#2,407/3,112 Sec#186/269
Trading
Volume	936,124 shares	US#1,540/3,112 Sec#151/269
Trading Value	$115M	US#823/3,112 Sec#48/269
Per Share
EPS	$-7.13	US—/3,112 Sec—/269
BPS	$7.08	US#2,036/3,112 Sec#101/269